IL10 and type 1 diabetes mellitus: The study done by group of researches analyzing monocytes in patients with advanced diabetes type 1 and type 2 showed that in patients with late diabetic complications prevails the anti-inflammatory profile with an enhanced IL-10 blood level and CD16+ monocytes are at lower frequency as compared with patients without complications.